On-Demand Webinar
Using Machine-Learning Algorithms to Prevent Drug Diversion at Mass General
Healthcare providers are vulnerable to serious legal, financial, operational and reputational risks–and regulatory fines–due to employee drug diversion and inadequate internal controls. COVID-19 has increased employee’s feelings of stress, and burnout has spiked to new levels. Furthermore, mounting evidence is showing the pandemic is increasing substance abuse across the country. To avoid potential risks, providers can use machine-learning algorithms together with advanced diversion prevention software to gain real-time dashboard views into their controlled substance supply chain to analyze behavior patterns among problem areas and suspected individuals. This presentation will be insightful for all leaders, particularly IT and clinical leaders.
As first presented at Scottsdale Institute
“New-age drug surveillance systems give us a lot more information to make better decisions. But they also are going to impact decision making around practice versus diversion issues. For instance, if a nurse pulls a drug and administers it, but takes an hour to come back to waste it and to document the waste, maybe that's not drug diversion, but it’s a practice issue.”
Christopher R. Fortier, PharmD, FASHP
Speakers
Christopher R. Fortier, PharmD, FASHP
Chief Pharmacy Officer, Massachusetts General Hospital, Partners HealthCare (Mass General Brigham)
Christopher Fortier is the Chief Pharmacy Officer at the Massachusetts General Hospital in Boston, MA. At MGH, he oversees a staff of 400 and all on-and off-campus inpatient, clinic, and retail pharmacy services. Chris is the Chair of the Partners Healthcare Chief Pharmacy Officers Council and works to move pharmacy strategic initiatives forward at the Partners system-level.
